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Epidemiological, clinical, physiological, cellular, and molecular evidence suggests that the origins of obesity and metabolic
dysfunction can be traced back to intrauterine life and supports an important role for maternal nutrition prior to and during
gestation in fetal programming. The elucidation of underlying mechanisms is an area of interest and intense investigation. In
this perspectives paper we propose that in addition to maternal nutrition-related processes it may be important to concurrently
consider the potential role of intrauterine stress and stress biology. We frame our arguments in the larger context of an
evolutionary-developmental perspective that supports roles for both nutrition and stress as key environmental conditions driving
natural selection and developmental plasticity. We suggest that intrauterine stress exposure may interact with the nutritional
milieu, and that stress biology may represent an underlying mechanism mediating the eﬀects of diverse intrauterine perturbations,
including but not limited to maternal nutritional insults (undernutrition and overnutrition), on brain and peripheral targets of
programming of body composition, energy balance homeostasis, and metabolic function. We discuss putative maternal-placental-
fetal endocrine and immune/inﬂammatory candidate mechanisms that may underlie the long-term eﬀects of intrauterine stress.
We conclude with a commentary of the implications for future research and clinical practice.
1.Introduction
A growing body of empirical evidence suggests that the
origins of obesity and metabolic dysfunction can be traced
back to the intrauterine period of life, at which time the
developing fetus is acted upon by and responds to subop-
timal conditions during critical periods of cellular prolifera-
tion,diﬀerentiation,andmaturationbyproducingstructural
and functional changes in cells, tissues and organ systems.
These changes, in turn, may have long-term consequences
to increase the individual’s risk for developing a range of
complex common disorders including, but not limited to,
obesity and metabolic dysfunction (i.e., the concept of
fetal programming of health and disease risk [1]). A large
number of human and animal studies of fetal programming
of obesity and metabolic dysfunction have focused on
the critical role of maternal nutrition prior to or during
gestationandhaveproducedimportantﬁndingsandinsights
(reviewed in [2–5]). Questions currently under investigation
in this context include those related to mechanisms or
pathways by which nutritional programming can exert life-
long eﬀects on the developing organism. Some of the major
nutrition-related pathways discussed in the current literature
relate to the eﬀects of maternal nutritional insults on2 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
maternal-placental-fetalglucose/insulinphysiologyandtheir
downstream eﬀects on the developing brain and peripheral
systems in the fetal compartment. In this perspectives
paper, we argue that it may be important to also simul-
taneously consider the potential role of intrauterine stress
and stress biology for the following reasons: (a) from an
evolutionary-developmental perspective, energy availability
(i.e., nutrition) and challenges that have the potential to
impact the structural or functional integrity and survival
of the organism (i.e., stress) represent the most important
environmental conditions underlying natural selection and
developmental plasticity along all time scales. It is therefore
likelyandplausiblethatstressrepresentsanimportantaspect
of the intrauterine environment that would be expected
to inﬂuence many, if not all, developmental outcomes. (b)
stress-related biological factors may exert direct eﬀects on
fetal targets of programming of body composition and
metabolic function. (c) many of the eﬀects of nutritional in-
sults (both undernutrition and overnutrition) may be
mediated by common stress-related pathways involving
the hypothalamic-pituitary-adrenal (HPA) axis and its end
product, cortisol. Hence, stress biology may represent a
commonunderlyingmechanism.(d)stressandstress-related
biological processes are known to alter nutrition at several
levels, including caloric intake, selection of food types, and
metabolic fate of energy. Conversely, nutritional status is
also known to alter stress at multiple levels in the brain and
periphery, including appraisals of potentially stressful cir-
cumstances,psychologicalandphysiologicalstressresponses,
and feedback regulation. Hence, in natural settings it is likely
that the eﬀects of either nutrition or stress are modiﬁed
by or conditioned upon the state of the other. In other
words, interaction eﬀects, and not main eﬀects, are the
more likely scenario underlying causation in the context of
complex common disorders including obesity and metabolic
function. This issue is particularly important in the human
context since nutritional insults and stress tend to cooccur in
populations across the world.
For these reasons, we highlight and review below the
eﬀects of stress and stress biology on fetal programming
of body composition, obesity, and metabolic function. We
review empirical evidence for interactive eﬀects between
stress and nutrition, describe ﬁndings from some of our
own recent studies on prenatal stress and stress biology,
and discuss putative maternal-placental-fetal endocrine and
immune/inﬂammatory candidate mechanisms that may
underlieandmediateshort-andlong-termeﬀectsofprenatal
stress on the developing human embryo and fetus, with
a speciﬁc focus on body composition, metabolic function,
and obesity risk. We conclude with a commentary of the
implications for research and clinical practice.
2. Rationale for Considering a Role for
Stress inFetal Programming
The origins of health and disease susceptibility for many
of the complex, common disorders that confer the major,
global burden of disease in developed societies as well as
other societies in rapid transition can be traced back to the
intrauterine period of life. Development is a plastic process,
wherein a range of diﬀerent phenotypes can be expressed
from a given genotype (contained within the fertilized
zygote). The unfolding of all developmental processes across
the multicontoured landscape from genotype to phenotype
is context-dependent, wherein the developing embryo/fetus
responds to, or is acted upon by, conditions in the internal
or external environment during sensitive periods of cellular
proliferation, diﬀerentiation and maturation, resulting in
structural and functional changes in cells, tissues, and organ
systems. These changes may, in turn, either independently
or through interactions with subsequent developmental
processes and environments, have short- and/or long-term
consequences for health and disease susceptibility. These
concepts have variously been referred to as the fetal or
developmental origins of health and disease risk [1, 6].
The rationale for considering a role for stress and stress
biology in fetal programming of child and adult obesity
and metabolic dysfunction derives, in part, from concepts
in evolutionary biology and developmental plasticity. From
conception onwards the mother and her developing fetus
both play an obligatory, active role in all aspects of devel-
opment. Based on the consideration that key environmental
conditions that have shaped evolutionary selection and
developmental plasticity include not only variation in energy
substrate availability (i.e., nutrition) but also challenges that
have the potential to impact the structural or functional
integrity and survival of the organism (i.e., stress), it
is likely and plausible that prenatal stress represents an
importantaspectoftheintrauterineenvironmentthatwould
be expected to inﬂuence many, if not all, developmental
outcomes [7]. Moreover, we submit the application of a
prenatal stress and stress biology framework oﬀers an excel-
lent model system for the study of intrauterine development
and associated developmental, birth and subsequent health-
related phenotypes because it is increasingly apparent that
the developing fetus acquires and incorporates information
about the nature of its environment in part via the same
biological systems that in an already-developed individual
mediate adaptation and central and peripheral responses
to endogenous and exogenous stress (i.e., the maternal-
placental-fetal neuroendocrine and immune systems [8]).
Another compelling rationale for considering a role
for in utero stress as a contributor to subsequent risk
of obesity and metabolic dysfunction derives from the
eﬀort to elucidate and better understand the underlying
reason(s) for the well-documented, persistent and large
socioeconomic and racial/ethnic disparities in the popula-
tion distribution of these outcomes in the US and other
developed nations. Many of the factors that disproportion-
ally aﬀect socially disadvantaged individuals, such as medical
care, diet/nutrition, and health-related behaviors, have been
shown to play only a limited role in accounting for these
disparities [9–12]. The search for alternate explanations has
led to the hypothesis that high levels of stress may, in
part, independently, or in combination with other factors,
account for these disparities, because the experience of
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of resources, and because stress and stress-related biological
processes have been implicated in a wide array of adverse
reproductive, developmental, and other health outcomes [9,
13].
A large body of the literature supports the notion
that conditions in the early postnatal period of life (e.g.,
behavioral or nutritional stress) can induce changes in
the metabolic, endocrine, cardiovascular, and behavioral
phenotypes, and these eﬀects could be independent of
prenatal exposures or could moderate or mediate the eﬀects
of prenatal adversity. Several of these ﬁndings are derived
from animal (rodent) models, in which maturational status
over the ﬁrst two weeks of postnatal life is approximately
equivalent to that of the human during the third trimester of
gestation. A comprehensive summary of the eﬀects of early
postnatal life stress is beyond the scope of the current paper,
but we refer to reader to excellent recent reviews on this topic
[14, 15].
3. The Role of Context:PotentialInteractive
Effects between Stress and Nutrition
Obesity and metabolic dysfunction are complex, multifac-
torial outcomes. At the individual level, the major risk
categories include sociodemographic, nutritional, historical,
biophysical, obstetric, behavioral, psychosocial, genetic, and
other environmental factors. Studies of the eﬀects of stress
and stress-related processes on these outcomes generally
treat other risk factors as potential confounding variables
and attempt to account (adjust) for their putative eﬀects by
either study design (subject selection criteria) or statistical
adjustment. However, emerging concepts of causation for
complex common disorders, including but not limited to
obesity and metabolic dysfunction, suggest it is not only
possible, but in fact probable, that causation does not reside
in any single factor or in the additive eﬀects of numerous
factors, but lies at the interface between multiple risk factors
(interaction or multiplicative [16]). We consider here, by
way of example and illustration of this critically important
concept, the potential interactive eﬀects between stress and
nutrition.
As discussed brieﬂy in the preceding section, the two
fundamental processes that are believed to shape evolution-
ary selection and developmental plasticity are variation in
energy substrate availability (nutrition) and challenges that
have the potential to impact the structural or functional
integrity and survival of the organism (stress). Maternal
nutrition, assessed by indicators of body size such as body
mass index (BMI), nutritional intake or serum measures
of nutritional biomarkers, is a well-established risk factor
for childhood and adult obesity and metabolic dysfunction.
Growing evidence supports the concept of a bidirectional
interaction between nutrition and stress, such that the eﬀects
ofnutritiononhealthmayvaryasafunctionofstress,orthat
the eﬀects of stress on health may vary as a function of nutri-
tional status. For example, several experimental studies in
animals have demonstrated that nutritional manipulations,
particularly in the preconception or early pregnancy period,
may produce their eﬀects on maternal and fetal outcomes
via alterations in stress biology (cortisol, inﬂammatory
cytokines [17–25]). Conversely, studies in animals and
humans of stress induction (by exposure to laboratory-based
stressors or endocrine stress analogues) have demonstrated
eﬀects on feeding behavior, food choice (high-calorie dense
food preference) and the metabolic fate of food in target
tissues [26–30]. For example, chronic stress or cortisol
administration motivates people to select high-fat food and
to overeat [26, 29], and corticotrophin-releasing hormone
(CRH) infusion in healthy human adults also increases
subsequent food intake [28]. Furthermore, chronic stress has
the potential to impair sleep, and short sleep duration is a
predictor of weight gain [31]. In addition, cortisol increases
insulinlevels[32,33].Althoughinsulinisanabolicandunder
normal basal conditions can increase both lean and fat mass,
coelevation of insulin with cortisol preferentially increases
abdominal fat stores [34, 35]. Further evidence of an interac-
tion between stress and nutrition comes from a recent study
in humans demonstrating that under conditions of stress
the brain’s energy need increases, and it actively “demands”
energy from the periphery (a concept termed “brain-pull,”
[36]).Itishypothesizedthatunderconditionsofhighenergy
demand the brain can activate its stress systems, that is, the
sympathetic nervous system (SNS) and the hypothalamus
pituitary adrenal (HPA) axis. Once stress networks in the
upper brain stem including the ventromedial hypothalamus
(VMH)andtheparaventricularnucleus(PVN)areactivated,
energy—particularlyglucose—isallocatedtothebrain.With
SNS activation, insulin secretion from the beta cells is
suppressed, and the insulin-dependent glucose uptake via
GLUT4 into the body periphery becomes limited, referred
to as “cerebral insulin suppression” (CIS). As a consequence
of CIS, glucose is available via insulin-independent GLUT1-
transport across the blood-brain barrier. This hypothesis
was tested using an experimental design, wherein healthy
young adults underwent a laboratory stress test and a control
session. Acute stress exposure increased carbohydrate intake
from a rich buﬀet compared to the control session. While
these stress-extra carbohydrates increased blood glucose
concentrations, they did not increase serum insulin concen-
trations. The ability to suppress insulin secretion was found
to be linked to the sympathoadrenal stress response [27].
The authors speculated that disturbances of this “brain-pull”
mechanism may be related to the onset of obesity, because
in the case of incompetent “brain-pull” food intake has to be
increased in order to ensure the brain’s energy supply under
conditions of stress [36].
We note that only a small number of studies have exam-
ined the relationship between maternal stress and diet or
nutritional state in pregnancy. A study by Hurley et al. [37]
found that pregnant women who were more fatigued,
stressed, and anxious in mid-pregnancy consumed more
food (increased macronutrient intake) but concurrently
decreased their intake of some micronutrients. Another
recent study demonstrated that the level of maternal stress
during pregnancy was positively associated with prepreg-
nancy BMI [38]. In an animal model, the interactive eﬀects4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
of maternal stress and nutrition on the subsequent risk of
oﬀspring obesity were investigated [24]. Pregnant rats were
maintained on standard or high-fat diet throughout gesta-
tion and lactation. Oﬀspring from dams that experienced
prenatal stress and/or were on a high-fat diet weighed more
beginning on postnatal day 7 compared to standard control
pups. Access to high-fat diet at weaning increased the body
weight eﬀect through early adulthood and was attributable
to greater adiposity. Furthermore, pups weaned on to a high-
fat diet had impaired glucose tolerance if their dams were on
a high-fat diet, experienced prenatal stress, or both [24].
Findings from a recent study on maternal high-fat
diet during pregnancy suggest that the eﬀects on oﬀspring
hypertension in adult life are mediated through an exacer-
bated sympathetic tone that arises very early in life [39]. We
note that increased sympathetic tone is also associated with
alterations in the stress response.
Despite the plausibility of stress-nutrition interaction
eﬀects in the context of pregnancy, we are not aware of any
human studies to date that have examined these interactive
eﬀects during pregnancy on oﬀspring body composition and
metabolic function.
4.Stress-RelatedMaternal-Placental-Fetal
EndocrineandImmuneProcessesas
PotentialMediatorsof FetalProgramming
of Health andDisease
The fetal programming hypothesis has led to the search
for underlying mechanisms by which disparate intrauterine
insults exert a multitude of eﬀects on diﬀerent physiological
systems in the developing oﬀspring. A question of particular
interest relates to whether these biological mechanisms are
exposure and/or outcome-speciﬁc, or whether there may
be some common mechanisms that mediate the eﬀects of
various exposures on a range of disparate outcomes. We
suggestthatstress-relatedmaternal-placental-fetalendocrine
and immune processes in gestation constitute an attractive
underlying common candidate mechanism because they are
responsive to many classes of intrauterine perturbations
and they act on multiple targets of fetal programming
[8, 40]. Unlike exposure to toxins and teratogens, it is
importanttoappreciatethefactthatmaternal-placental-fetal
hormones and cytokines play an essential and obligatory
role in orchestrating key events underlying cellular growth,
replication and diﬀerentiation in the brain and peripheral
tissues [41–46]. Thus, perturbations in the level and/or
time of exposure of these biologic eﬀectors are likely to
produce alterations of normal structure and function. It is
also important to appreciate that the state of pregnancy itself
produces major and progressive alterations in the function
of these systems, and that these changes may have important
implications for altering the responsivity of these systems
to exogenous or endogenous perturbations and hence their
downstream eﬀects on fetal targets of programming.
4.1. Stress Biology in Human Pregnancy. Stress biology refers
to the set of biological adaptations in response to challenges
or demands that threaten or are perceived to have the
potential to threaten the stability of the internal milieu of the
organism. The nervous, endocrine, immune, and vascular
systems play a major role in adaptations to stress. There
are no direct neural, vascular, or other connections between
the mother and her developing fetus—all communication
between the maternal and fetal compartments is mediated
via the placenta, an organ of fetal origin. Based on the
physiology of stress, parturition and the evidence linking
maternal stress to earlier delivery, we have previously
proposed a biobehavioral framework of stress and adverse
birthoutcomes[8],thatmayalsobeapplicableinthepresent
context.
Pregnancyproducesmajoralterationsinneuroendocrine
and immune function, including changes in hormone and
cytokine levels and control mechanisms (feedback loops),
that are crucial in providing a favorable environment within
the uterus and fetal compartment for growth, diﬀerentiation
and maturation, and conveying signals when the fetus is
ready for extrauterine life. Starting very early in gestation
the placenta, the ﬁrst fetal organ to develop and function,
produces hormones, neuropeptides, growth factors, and
cytokines, and appears to function in a manner resembling
that of compressed hypothalamic-pituitary-target systems
[47].
4.1.1. Maternal-Placental-Fetal Stress-Related Endocrine
Function. Glucocorticoid physiology (cortisol in humans)
has received extensive and well-placed consideration
as a critical endocrine mediator of fetal programming,
with an emphasis on not only hormone production
but also hormone action mediated by tissue-speciﬁc
glucocorticoid receptor expression, sensitivity and aﬃnity,
and by maternal-fetal transfer mediated by the activity of the
placental 11β-hydroxysteroid dehydrogenase enzyme system
(see [48] for a recent review). Less well recognized is the
potential and perhaps equally important role of the peptide
corticotrophin-releasing hormone (CRH). In primates,
but not other mammals, the placenta synthesizes and
releases CRH in large amounts into the fetal and maternal
circulations. In contrast to the inhibitory inﬂuence on
hypothalamic CRH production, cortisol stimulates placental
CRH production [49], and this positive feedback loop
results in a progressive ampliﬁcation of CRH and cortisol
production over the course of gestation [50].
4.1.2. Maternal-Placental-Fetal Stress-Related Immune Func-
tion. With respect to the immune axis, a major endeavor
of pregnancy-related alterations in immune function is
to achieve and maintain the optimal balance between
tolerating the fetal semiallograft while not suppressing
maternal immune responses to an extent that increases
maternal or fetal susceptibility to infection. Thus, a gener-
alized reduction of maternal immune responsiveness occurs
during pregnancy, mediated by hormonal changes (e.g.,
increased levels of progesterone), trophoblast expression of
key immunomodulatory molecules, and a progressive switch
fromaTH1/TH2 balancetoapredominantly T-helper2-type
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4.1.3. Interactions between Maternal-Placental-Fetal Neu-
roendocrine, Immune-Inﬂammatory, and Vascular Path-
ways in Pregnancy. Although distinct neuroendocrine,
immune/inﬂammatory, and vascular pathways have been
described, growing evidence suggests that these and other
physiological systems involved in pregnancy are highly
interrelated, and that they extensively regulate and coun-
terregulate one another. The potential complexity of the
interrelationships among these physiologic systems is seen
when considering the role of infection in the etiology of
adverse fetal developmental and birth outcomes. For exam-
ple, inﬂammatory cytokines that are produced in response
to infection, such as TNF-α,I L - 1 β,a n dI L - 6 ,c a na c t i v a t e
components of the MPF neuroendocrine system [52–54].
Conversely, it is also known that HPA hormones such as
CRH and cortisol inﬂuence the production of cytokines
and modulate the inﬂammatory response to infection [55–
57]. Central CRH, acting via glucocorticoids and cate-
cholamines, inhibits inﬂammation, whereas CRH directly
secreted by peripheral nerves and mast cells stimulates local
inﬂammation [58]. Impaired nutrient and oxygen exchange
associated with uteroplacental vasculopathy may stress the
fetus and result in increased production of placental-fetal
hormones such as CRH, while placental CRH, in turn, may
inﬂuence fetal-placental circulation [59]. Thus, the rela-
tionship between immune and endocrine alterations during
pregnancy to adverse metabolic outcomes and increased
risk of obesity on the oﬀspring is likely to involve complex
interactions between the endocrine, immune, and vascular
systems.
4.2. Prenatal Stress and Maternal-Placental-Fetal Endocrine
a n dI m m u n eF u n c t i o n . Substantial evidence in nonpregnant
humans and animals demonstrates that stress exposure
produces activation of the neuroendocrine system (e.g., HPA
axis)andexaggeratedinﬂammatoryresponses[60,61];how-
ever, these associations cannot be assumed to also be present
in the pregnant state because the above-described changes
in endocrine and immune physiology have consequences for
attenuating the responsivity of these systems to stress. With
respect to prenatal psychosocial stress-related biological
pathways, some of our earlier studies were among the ﬁrst
to demonstrate that despite the large pregnancy-associated
changes in maternal endocrine physiology, the system is
responsive to maternal psychosocial states (such as high
stress and low social support) [62]. Our more recent studies
on maternal stress responses in human pregnancy are among
the ﬁrst to demonstrate that maternal psychophysiological
stress responses are progressively attenuated with advancing
gestation [63], and that after accounting for the eﬀects of
other established risk factors, the degree of attenuation is
a signiﬁcant predictor of shortened length of gestation and
earlier delivery [64].
Studies by other groups have reported that elevated
psychosocial stress in pregnant women is associated with
higher circulating levels of inﬂammatory markers like C-
reactive protein (CRP) and the proinﬂammatory cytokines
IL-1b, IL-6, and TNF-α, with lower circulating levels of
the anti-inﬂammatory cytokine IL-10 and ex vivo endo-
toxin (LPS)-stimulated levels of IL-1b and IL-6 [65, 66].
Another recent study of pro-inﬂammatory responses to an
in vivo antigen challenge (inﬂuenza virus vaccination) in
pregnant women reported an association between depressive
symptoms and sensitization of the inﬂammatory cytokine
responses [66].
In addition to psychosocial stress, substantial in vitro
and in vivo evidence indicates that maternal-placental-fetal
endocrine and immune processes during pregnancy respond
toavarietyofothermaternalandintrauterineperturbations,
including biological eﬀectors of stress [67–72], obstetric
risk conditions such as preeclampsia, pregnancy-induced
hypertension[57–70],gestationaldiabetes[73,74],infection
[75–78], reduced uteroplacental blood ﬂow [79, 80], and
behavioral factors such as the constituents of maternal diet,
over- and under-nutrition, and smoking [17–23, 81, 82].
Based on these ﬁndings, it is apparent that measures of
maternal-fetal endocrine and immune/inﬂammatory stress
markers capture physiological responses to a wide range
of intrauterine perturbations including, but not limited to
prenatalstress.Inaccordancewithoursuggestionthatstress-
related maternal-placental-fetal endocrine and immune
processes in gestation constitute an attractive candidate
mechanism for fetal programming, a recent JAMA editorial
[83] on an article reporting an increase in the prevalence
of several categories of chronic illness in childhood, includ-
ing obesity, asthma, and ADHD [84], speculates that there
may be common early risks underlying these conditions
that are triggering development of aberrant physiologic
pathways. The editorial suggests that adverse early experi-
ences that aﬀect stress-sensitive physiologic systems (endo-
crine/metabolic, immune) may contribute to not only the
onset of childhood illness but also predispose the same
individuals to develop age-related diseases as adults.
5. Long-Term Effects of Prenatal
Stress Exposure on Human Adult Physiology
andHealth
The majority of human epidemiologic studies of the fetal
programming hypothesis have operationalized unfavorable
intrauterine environments using indicators of adverse birth
outcomes such as low birth weight. We and others have
argued that the long-term eﬀects on child or adult disease-
related phenotypes of interest may not necessarily be medi-
ated by adverse birth outcomes. For example, several experi-
mental studies in animals suggest that maternal exposure to
psychosocial stress during gestation can independently exert
long-term eﬀects on several central and peripheral systems
in the oﬀspring, and that titration of the prenatal stress
exposure dose can produce signiﬁcant long-term eﬀects
without necessarily altering the birth phenotype [85–89].
However, only a very small number of studies have inves-
tigated this issue in humans. As a ﬁrst step to addressing
this question, we conducted a study using a retrospective
case-control design in a sample of healthy young adults
born to mothers with healthy pregnancies and normal birth6 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
outcomes. One half of the study population of young adults
was born to mothers who had experienced a major stressful
life event during the index pregnancy (prenatal stress group
(PS)), whereas the other half was a sociodemographically
matched population with no history of maternal exposure to
prenatalstress(comparisongroup(CG)).Weselectedastudy
population of younger as opposed to older adults in order to
focus on predisease markers of physiological dysregulation
of metabolic, endocrine, and immune systems as early
predictors of disease susceptibility. The potential eﬀects of
other established obstetric, newborn, and childhood risk
factors on adult health were controlled using a stringent set
of exclusionary criteria. Maternal and child medical records
were obtained and screened to exclude presence of any
maternal acute or chronic diseases, obstetric complications
(e.g., gestational diabetes, hypertension/preeclampsia, and
infection), unhealthy behaviors (smoking), adverse birth
outcomes (preterm birth, low birth weight), newborn com-
plications, and history of any major childhood or current
diseases (obesity, diabetes, asthma, and adverse neurodevel-
opmental or psychiatric conditions). Study assessments were
performed to quantify health and physiological markers of
disease risk, including (i) body composition and glucose-
insulin metabolism (BMI and percent fat mass; basal and
postoral glucose tolerance test levels of glucose, insulin,
leptin, adiponectin; fasting lipid proﬁle), (ii) endocrine
function (basal and post behavioral/pharmacological stress
levels of pituitary-adrenal stress hormones, chronobiological
regulation of adrenal function, and assessment of HPA-
axis feedback sensitivity), (iii) immune function (immune
cell traﬃcking and phytohemagglutinin (PHA)-stimulated
production of pro- and anti-inﬂammatory and TH1/TH2
cytokines), (iv) cognitive function (working memory under
basal and hydrocortisone conditions), and (v) cellular aging
(as indexed by leukocyte telomere length). Because subtle
physiological diﬀerences in disease susceptibility are often
not detected in basal state, we employed appropriate chal-
lenge tests to quantify the function of these systems under
stimulated conditions (e.g., oral glucose challenge, ACTH
stimulation test, PHA-stimulated immune responses, and
working memory after cortisol administration).
Our results (summarized in Table 1) indicated that the
young adults exposed during intrauterine life to maternal
psychosocial stress consistently exhibited signiﬁcant dysreg-
ulation of all these key physiological parameters, thereby
placing them at increased risk for developing complex
common disorders. Speciﬁcally, individuals in the PS group
exhibited higher BMI and percent body fat, primary insulin
resistance, and a lipid proﬁle consistent with the metabolic
syndrome [90]; altered immune function with a TH2 shift
in the TH1/TH2 balance (consistent with increased risk of
asthma and autoimmune disorders [92]); altered endocrine
function, with an increased ACTH and reduced cortisol
levels during pharmacological and psychological stimula-
tion paradigms (consistent with the high-risk endocrine
proﬁle exhibited by individuals exposed to early life abuse
[95]); accelerated cellular aging (as indexed by shortened
leukocytetelomerelengththatextrapolatedtoapproximately
a 3.5-year increase in the rate of cell aging [82]); and
impaired prefrontal cortex (PFC)-related cognitive perfor-
mance (impairments in working memory performance after
hydrocortisone administration) [93]. Interestingly, stress-
related changes in PFC function are believed to play a role
in alterations of hypothalamic energy balance homeostasis
circuits and obesity risk (see, for example, [96, 97]) thereby
suggesting that prenatal stress may program brain regions
that are associated with the control of energy intake.
Consistent with the ﬁnding on cognitive function are results
from one of our other recent prospective, longitudinal
studies on the long-term eﬀects of prenatal stress (anxiety)
on child brain morphology. After excluding cases with low
birth weight and adjusting for total gray matter volume,
age, gestational age at birth, handedness, and postpartum
stress, maternal pregnancy-speciﬁc anxiety in mid-gestation
was associated with gray matter volume reductions in several
child brain regions, including the prefrontal cortex [98].
Taken together, our ﬁndings suggest that in utero
exposuretoprenatalpsychosocialstressmayconferincreased
long-term risk of a range of negative physiological and
cognitive health outcomes in humans; these eﬀects are
independent from those of other established obstetric and
childhood risk factors; these long-term eﬀects are not
necessarily mediated by unfavorable birth outcomes. It
is noteworthy that our above-described ﬁnding on body
composition is consistent with a more recent report in
a large, national cohort sample linking prepregnancy and
prenatal stress exposure related to maternal bereavement
to risk of childhood overweight [99], and our ﬁnding on
immune function is consistent with another recent report
linking prenatal maternal anxiety with infant illnesses and
antibiotic use [100]. We also note that our ﬁndings on
prenatal stress-associated altered immune, endocrine, cell
aging, and cognitive function all converge in a manner
consistent with the programming of body composition,
obesity risk, and metabolic dysfunction.
6. Fetal Programmingof Body Composition,
Metabolic Function,and ObesityRisk
Continuing with the theme of a common underlying biolog-
ical mechanism, in this section we address the issue of the
potential impact of intrauterine stress biology on multiple
targets of fetal programming related to body composition,
metabolic function and obesity risk (see also [40]).
Obesity (or, to be more precise, adiposity) is recognized
as one of the most serious health problems in the US
and other societies. At the individual level, obesity results
when energy intake exceeds energy expenditure. However,
the relationship between excess energy intake and adiposity
is not linear and monotonic; there is wide variation among
children or adults at identical levels of excess energy intake
in their propensity to gain weight and accrue fat mass.
This variation across individuals deﬁnes susceptibility for
developing obesity/adiposity. Once an individual becomes
obese, it is diﬃcult to lose weight, and even more diﬃcult
to sustain weight loss, because of the remarkable eﬃciency
of energy balance homeostasis mechanisms [101–103]. ForJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 7
Table 1: Long-term eﬀects of prenatal stress exposure in young adults: summary of our studies.
Outcome Finding Potential implications Reference
Body composition and
metabolic function
↑ BMI; ↑ % body fat
↑ Insulin 2h after oral glucose tolerance test
↑ Leptin
↓ Fasting HDL; ↑ fasting VLDL
Risk for cardiometabolic
disorders/type 2 diabetes
Entringer et al. 2008
Am J Ob Gyn [90]
Endocrine system
↑ ACTH, ↓ cortisol in response to psychosocial stress test
↓ Cortisol levels in response to ACTH1−24 stimulation test
Susceptibility for
psychosomatic disorders
Entringer et al. 2009
Horm Behav [91]
Immune system TH2 shift in TH1/TH2 balance after PHA stimulation
↑ IL-6, IL-10 after PHA stimulation
Risk for allergies, atopic
disease, and asthma
Entringer et al. 2008
Dev Psychobiol [92]
Cognitive function
↓Working memory performance after hydrocortisone
administration
Impaired prefrontal
cortex-related executive
function
Entringer et al. 2009
Behav Neurosci [93]
Cellular aging ↓ Leukocyte telomere length Risk for age-related
degenerative disorders
Entringer et al. 2011
PNAS [94]
BMI: body mass index; HDL: low-density lipoprotein; VLDL: very low-density lipoprotein; ACTH: adrenocorticotrophic hormone; PHA: phytohemagglu-
tinin; TH: T-helper cell; IL: interleukin.
these reasons, it is important to gain a better understanding
of the origins of individual diﬀerences in the propensity for
weight and fat mass gain, in order to predict obesity risk and
develop strategies for primary prevention [102].
6.1. Targets of Programming of Obesity: Potential Role of
the Maternal-Placental-Fetal Endocrine and Immune/Inﬂam-
matory Pathway. It is well established that the primary
targets of programming of body composition, metabolic
function, and obesity risk are the neural networks that
regulate energy balance (appetite, feeding, and basal energy
expenditure) and peripheral organs and tissues involved
in fat synthesis/breakdown, storage and metabolic function
(adipocyte, liver, pancreas, and muscle). In this section, we
consider and review ﬁndings that pertain to the potential
role of prenatal stress biology in programming these major
targets of interest (see Figure 1).
Stress-related endocrine and immune processes in
human pregnancy are associated with not only fetal devel-
opment and birth outcomes but also with later disease
risk. For example, we have reported that placental CRH
concentrations in human pregnancy signiﬁcantly predict
the rate of fetal growth and size at birth [104], which,
in turn, is a signiﬁcant predictor of childhood and adult
adiposity [105–107]. Other researchers have found a positive
associationbetweenCRHlevelsinpregnancyandanincrease
in central adiposity [108] and alterations in adiponectin
levels in 3-year-old children [109]. Yet others have reported a
positive association between maternal levels of interleukin-
6 (IL-6) in pregnancy and neonatal adiposity [110]. In a
recent large epidemiological study in humans, Li et al. [101]
found an association between maternal bereavement from
death of someone close during pregnancy and an increased
risk of overweight in the oﬀspring in later childhood.
Furthermore, animal studies have demonstrated long-term
eﬀects of prenatal stress exposure on increased body weight
in the oﬀspring [24, 111].
6.1.1. Neural Circuits. The central role of ventromedial
hypothalamic (VMN) circuits in regulating feeding and
energy balance is well established. VMH neurons contain
receptors for and receive aﬀerent signals related to fat stores
(leptin), nutrient metabolism (insulin), hunger (ghrelin),
and satiety (peptide YY), and they integrate peripheral
signals of eﬀectors of food intake and energy expenditure
so as to prevent substantial variations in the level of energy
balance [112]. Also involved in the regulation of appetite
and food intake are brain regions that make food intake
rewarding (limbic structures), and higher cortical structures
(e.g., prefrontal cortex) that are important for learned
patterns of eating behavior and executive control [96]. A
growing body of the literature suggests that intrauterine
perturbations can produce reorganization of these neural
pathways that regulate energy intake and expenditure in
ways that enhance the development of obesity. Several
studies have convincingly demonstrated that biological
(endocrine, immune) stress during gestation, triggered by
a variety of nutritional, inﬂammatory, vascular, behavioral,
or psychosocial perturbations, can promote obesity in the
oﬀspring by reorganizing central neural pathways through
programming of energy balance “set points.” (see [113]f o r
recent review). One key system involved in the regulation
of energy balance is the hypothalamic (CRH)-pituitary
(ACTH)-adrenal(cortisol)neuroendocrinestressaxis,which
forms a network of neuronal pathways capable of interacting
with brain circuits controlling energy balance [114]. For
instance,theadipogenichormoneleptinwhichistheaﬀerent
loop informing the hypothalamus about the states of fat
stores, participates in the expression of hypothalamic CRH,
interacts at the adrenal with ACTH, and is regulated by
cortisol. Cortisol increases leptin secretion and limits CNS
leptin-induced eﬀerents [115].
6.1.2. Adipocytes. Obesity is impacted by increases in fat cell
number, size, or both. Fetal adipose tissue development is
regulated by the complex interaction of maternal, endocrine,8 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
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Figure 1: Intrauterine stress biology and programming of fetal targets of body composition and metabolic function. Adverse circumstances
duringpregnancy(physiologicalaswellaspsychologicalstressors,summarizedhereas“prenatalstress”)havethepotentialtoinducechanges
in maternal-placental-fetal stress biology (e.g., increases in maternal and fetal cortisol, placental corticotrophin-releasing-hormone (CRH),
and inﬂammatory mediators). The subsequent increase in stress hormones and proinﬂammatory cytokines in the fetal compartment during
sensitive or critical developmental windows can impact the structure and function of the brain and peripheral targets (e.g., adipose tissue,
pancreas, and liver) that are related to body composition, energy balance homeostasis, and metabolic function.
and paracrine inﬂuences that initiate speciﬁc changes in
angiogenesis, adipogenesis, and metabolism [116]. Adipo-
genesis, the process of adipocyte development from mes-
enchymal stem cell precursors, occurs primarily during late
fetal and early postnatal life in humans, and the number of
adipocytes is relatively ﬁxed after young adulthood [116–
118], supporting the notion that fetal and early postnatal
periods are crucial windows in the development of adipose
depots. Adipogenesis is highly sensitive to the intrauterine
biological environment, in particular to concentrations of
insulin-like growth factors, glucose, insulin, and glucocor-
ticoids [116, 117]. In vitro studies could show that the
diﬀerentiation of human adipocyte precursor cells in the
presence of insulin is stimulated by cortisol in a dose-
dependentmannerandoccuratphysiologicalconcentrations
[119, 120]. Furthermore, in vitro exposure of isolated human
adipocytes to insulin and corticosteroids synergistically
inducesperoxisomeproliferator-activatedreceptor(PPAR-γ)
mRNA expression [121].
CRH seems to be an important regulator of adipocyte
function, and CRH receptors are expressed in both white
and brown adipocytes [122]. The role of cytokines as
regulators of adipose tissue metabolism is well established.
Proinﬂammatory cytokines are elevated in obese individuals,
and they seem to modulate leptin secretion from adipocytes
[123]. Furthermore, in an animal study prenatal exposure to
pro-inﬂammatory cytokines or dexamethasone had an eﬀect
onincreasedfatdepotsintheoﬀspring[124].Animalstudies
have shown that fat cells exposed to an excess substrate
supply during crucial windows in their development have
an increased capacity for storing lipid in postnatal life
[125, 126]. This enhanced lipogenic capacity renders these
individuals more likely to store excess energy in the form
of fat and increases their susceptibility to weight gain and
obesity and its metabolic sequelae. In individuals exposed to
low nutrition levels before birth, adipocyte development is
initially sacriﬁced in favor of “essential” organs [4, 127]. If
an in utero “restricted” individual is born into a postnatal
environment in which nutrient supply is no longer con-
strained, a period of “catchup” fat deposition ensues, mainly
in the visceral adipose depot [128]. These individuals are at
increased risk of visceral obesity [107] and, consequently, to
the development of insulin resistance and type 2 diabetes
[129].
6.1.3. Liver and Pancreas. The liver controls the production
and fate of metabolic fuels through the action of hepatic
enzymes. Phosphoenolpyruvate carboxykinase (PEPCK), a
key enzyme in hepatic gluconeogenesis, is under potent
glucocorticoid regulation. In animals, prenatal exposure to
dexamethasone produces an increased expression of hepatic
glucocorticoid receptors as well as increased levels and
activity of PEPCK [130], thereby predisposing these animals
to glucose intolerance later in life. Furthermore, manip-
ulation of diet during pregnancy is associated with epi-
genetic changes in the promotor regions of the genes
encoding PPARα and the glucocorticoid receptors in the
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phenotype [131, 132]. Insulin is produced by the beta cells
in the pancreas in response to elevated blood glucose levels.
Increased glucocorticoid exposure and malnutrition during
fetal development have the potential to permanently reduce
the pancreatic beta cell mass and lower pancreatic insulin
content, thereby increasing the risk for metabolic disease
later in life (reviewed in [133]). For example in humans,
prenatal exposure to glucocorticoids or stress was associated
withhigherinsulinresistanceintheadultoﬀspring[90,134].
6.2. Genes, Gene-Environment Interactions, and Epigenetic
Mechanisms. The ascertainment of genetic contributors to
body composition, obesity, and metabolic dysfunction is an
area of active and intense investigation. Although weight and
body composition are highly heritable, known genes account
for only a modest proportion of their variance [135–137].
Genetic makeup alone cannot explain the rapid increase in
obesity prevalence in the population because the genetic
characteristics of the human population have not changed
in the last three decades, but the prevalence of obesity
has tripled during that time [138]. Estimates of maternal
transmission of heritability are stronger than those for
paternal transmission, which argues in favor of intrauterine
eﬀects and/or mitochondrial DNA eﬀects. Moreover, the
strongest genetic associations seem to vary as a function of
the environment (e.g., eﬀects are seen at speciﬁc times but
not other times in the life cycle). These observations suggest
gene-environment interactions are particularly relevant in
the context of the obesity phenotype.
The search for mechanisms by which environmental
conditions during development can produce long-term
changes in the structure and function of cells, tissues, and
organ systems has led to the identiﬁcation and study of
epigenetic processes in the context of fetal programming
of health and disease risk. A detailed review of epigenetics
is beyond the scope of the current paper, and we have
elaborated on this issue elsewhere [139, 140]. The eﬀects of
nutritional conditions in early development on epigenetic
processes have been studied extensively (for recent reviews
see, for example, [6, 141–147]).
We suggest that the incorporation of the genetics and
epigenetics of stress and stress biology in the context
of fetal programming of body composition, obesity, and
metabolic function is likely to yield additional important
information that supplements and complements investiga-
tions of nutrition-mediated genetic and epigenetic processes
underlying fetal programming. As discussed above, many of
the eﬀects of maternal nutrition on the developing embryo
and fetus may be mediated, in part, by stress hormones such
as CRH and cortisol. Diet in prenatal or early postnatal
life has been shown to alter the methylation status of
several genes implicated in stress and stress physiology,
including genes encoding the glucocorticoid receptor and
proopiomelanocortin[141].Conversely,intrauterineorearly
postnatalexposuretoinappropriatelevelsofstresshormones
such as glucocorticoids is known to produce a wide array
of epigenetic modiﬁcations in tissues including the placenta,
brain, adipose tissue, liver, lungs, kidney, skeletal muscle,
heart, and blood vessels (for a recent review see [148]). Many
of these changes have important long-term implications for
body composition and metabolic function. Interestingly, a
variant in the gene encoding the glucocorticoid receptor
has been associated with increased body fatness in children
[149]. We and others have described the association of
the same variant with altered physiological stress responses
[150]. Furthermore, manipulation of maternal behavior in
the early postnatal period in rats permanently alters the
oﬀspring’s epigenome at the glucocorticoid receptor gene
promoter in the hippocampus, and this altered methylation
state is associated with changes in GR expression and
hypothalamic-pituitary-adrenal (HPA) responses to stress in
the oﬀspring [151].
With respect to the issue of the contribution of stress
and stress biology it is very likely that genetic and epigenetic
variations will be determined to play an important role
in moderating the association between intrauterine stress
and obesity and metabolic dysfunction risk via maternal-
fetal gene-gene and gene-environment interactions at mul-
tiple levels, originating with the likelihood of encountering
stressful life circumstances, and culminating in modifying
the eﬀects of stress-related biological processes on relevant
target tissues. For example, women who are carriers of
certain genotypes (high-risk alleles in dopamine-related
genes) may be more likely to place themselves in stressful
life circumstances [152–154]. The psychological appraisal
of potentially stressful circumstances may be inﬂuenced
directly by the maternal genotypic variation (e.g., in the
serotonin transporter gene [155]) or indirectly by the fetal
genotype (via its eﬀect on alterations in maternal physiology
that, in turn, inﬂuence maternal psychological appraisals).
Next, the ensuing eﬀects of maternal stressful experience
on maternal and fetal biology may be moderated by the
geneticandepigeneticcharacteristicsofthemotherandfetus
(e.g., variants in the glucocorticoid receptor gene [156]),
respectively. Finally, the eﬀects of stress-related physiological
alterations on target placental and fetal tissues implicated in
energy balance homeostasis and metabolic function may be
further inﬂuenced by the genetic and epigenetic makeup of
the mother and fetus, respectively.
To date, only a small number of studies have sys-
tematically addressed the issue of a genetic predisposi-
tion for susceptibility to psychosocial stress and related
psychobiological states. For example, we and others have
described that certain polymorphisms in the promotor
region of the gene encoding the glucocorticoid receptor are
associated with changes in the regulation of the HPA axis at
diﬀerentlevelsincludingbasallevel,feedbackregulation,and
response following a psychosocial stressor (summarized in
[156]). Because several genes that code for proteins involved
in the regulation of the stress response also are involved in
the physiology of pregnancy and fetal development (e.g.,
CRH, cortisol, IL-6, etc.), individual diﬀerences in genetic
variation may be another factor underlying susceptibility in
terms of the potentially adverse eﬀects of maternal stress on
pregnancy outcomes. The participation of placental CRH as
acentralmoleculeinregulatingvariousaspectsofpregnancy,
fetal development, and birth outcomes has been discussed
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the CRH gene, the CRH receptor genes, the glucocorticoid
receptor gene, and other genes encoding key enzymes and
binding proteins in their biosynthetic pathways may have
important implications in this context.
Genetic and epigenetic mechanisms have been proposed
to explain the observed racial/ethnic disparities in obesity
and metabolic diseases, particularly with respect to the
hypothesized contribution of prenatal stress. These observed
racial/ethnic disparities are commonly assumed to reﬂect
the burden of adverse societal conditions associated with
minority racial/ethnic status in the US. Prenatal stress is a
plausible mediator of the eﬀects of race/ethnicity via one
or both of two possibilities: greater cumulative exposure
to stress and greater vulnerability to the eﬀects of stress
(arising from diﬀerences in psychobiological responses to
stress). The characterization of racial/ethnic diﬀerences in
DNA sequence or epigenetic variation in genes associated
with the stress response will prove particularly informative
in this regard. For instance, we and others have previously
reported signiﬁcant racial/ethnic diﬀerences in stress-related
hormonal states in human pregnancy [157, 158]. These
racial/ethnic diﬀerences in neuroendocrine function in preg-
nancy may, in turn, reﬂect one or more of three possibili-
ties: ﬁrst, that particular genetic variations associated with
pathophysiology are more frequent in speciﬁc racial/ethnic
populations. Second, that there are no diﬀerences in the
frequency of particular genetic variations across popula-
tion subgroups; however, they are phenotypically expressed
only under certain environmental conditions or exposures
associated with particular racial/ethnic populations (e.g.,
high stress, reproductive tract infection, social or cultural
behavioral practices). And third, that there are no diﬀerences
in the frequency of particular genetic variations across
population subgroups; however, speciﬁc gene regions are
preferentially expressed or silenced by epigenetic modiﬁca-
tions that occurred during sensitive or critical periods of the
mother’s own development under environmental conditions
associated with particular racial/ethnic populations (e.g.,
intrauterine exposure to high stress or infection [159]).
One of our ongoing projects is in the process of evaluating
these possibilities by determining whether the popula-
tion structure and functional signiﬁcance of maternal-fetal
genetic variation and gene-environment interactions vary as
a function of race/ethnicity.
7. FutureDirections:Implications for
Research andClinicalPractice
By incorporating the developmental programming approach
into the traditional paradigm of causation of complex
common health disorders, the focus shifts to placing a far
greater emphasis on the health and well being of young
women of reproductive age prior to conception and across
gestation, in order to more eﬀectively address health and
disease risk-related issues in their oﬀspring from infancy
and childhood through adolescence and into adult life.
A multilevel approach is required that includes molecular
and cellular studies, the use of appropriate animal mod-
els, and well-designed human studies. In the context of
human research, opportunities are limited for experimental
manipulations of prenatal stress and the intrauterine envi-
ronment, and for access to many of the target tissues of
interest, particularly in fetal life. Hence, for future research
purposes, the value of prospective, longitudinal, follow-up
studies, ideally starting before conception, and extending
through pregnancy and birth into childhood and beyond,
is emphasized. For these studies, deployment of state-of-the
art methods, including the assessment of metabolomic and
gene expression proﬁles to precisely characterize maternal
nutritional biomarkers and their interactive eﬀects with
stress biology during pregnancy, 3D/4D fetal ultrasonogra-
phy for quantiﬁcation of fetal growth (biometry), regional
blood ﬂow (uterine, umbilical, and cerebral), hepatic and
renal volume [160, 161], growth trajectory of organs
(placenta, brain, liver, kidneys, and adrenals [162, 163])
and body composition (arm, thigh, and visceral fat/lean
mass [164, 165]), coupled with reliable assessments in
newborns, infants and children of body composition (with
magnetic resonance imaging (MRI) or dual energy X-
ray absorptiometry (DXA)) and energy expenditure (basal
metabolic rate and total energy expenditure using indirect
calorimetry and the doubly labeled water method (DLW),
resp.), will move the ﬁeld forward in an informed manner.
Furthermore, recent advances in imaging techniques will
likely enable the developments of protocols in infants and
children for subcutaneous and visceral fat quantiﬁcation
(especially intrahepatic fat) [166], and characterization
of and diﬀerentiation between white and brown adipose
tissue [167]. These observational studies, in conjunction
with parallel molecular studies including studies of human
placental, multipotent (stromal) stem cells, and adipose
tissue culture systems [168], and coupled with state-of-
the-art statistical modeling techniques for parametric and
nonparametric repeated measures, time-series data [169–
172],willcontributetofurtherdeﬁningtechnicalcapabilities
in this ﬁeld.
Regarding clinical implications, it is apparent that cur-
rent approaches to the prevention and management of
obesity and associated metabolic disorders have yielded only
very limited success. Once an individual becomes obese, it
is diﬃcult to lose weight, and even more diﬃcult to sustain
weight loss [101–103]; systematic studies of the eﬃcacy of
c u r r e n tw e i g h tl o s sp r o g r a m sh a v ep r o v i d et h es o b e r i n g
statistic that approximately 80–90% of obese people who
have lost weight regain it within one year [173–175]. Clearly,
it is critical to adopt a developmental framework in order to
arrive at a better understanding of the origins of individual
diﬀerences in the propensity for weight and fat mass gain,
and to develop and test hypotheses that set the stage for
translationalresearchtoinformthesubsequentdevelopment
of primary intervention strategies before an individual
becomes overweight or obese, or secondary interventions to
increase the likelihood of a favorable and more sustained
response to weight loss strategies.
8. Conclusion
Based on the conceptual framework and empirical ﬁndings
presented here, we suggest that in addition to maternalJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 11
nutrition it is important to also consider the potential role
of intrauterine stress and stress biology in arriving at a better
understandingofdevelopmentalprogrammingofhealthand
diseasesusceptibility.Moreover,wesubmitthatstress-related
maternal-placental-fetal endocrine and immune processes in
humangestationrepresentapotentiallyattractiveunderlying
candidate mechanism for elucidating the common biological
basis (pathway) for mediating not only the long-term eﬀects
ofprenatalstressbutalsothoseofahostofotherintrauterine
perturbations including maternal over- and under-nutrition
that have been implicated in this area.
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